Search
What are you looking for?
Start main content

Press Releases

Press Releases

https://www.med.cuhk.edu.hk/press-releases/why-is-liver-cancer-more-prevalent-in-men-than-in-women-cuhk-discovers-a-sex-hormone-controlled-gene-that-promotes-liver-cancer
https://www.med.cuhk.edu.hk/press-releases/why-is-liver-cancer-more-prevalent-in-men-than-in-women-cuhk-discovers-a-sex-hormone-controlled-gene-that-promotes-liver-cancer

Why is Liver Cancer More Prevalent in Men than in Women? CUHK Discovers a Sex Hormone-controlled Gene that Promotes Liver Cancer

Liver cancer is the fourth most common cancer and the third most frequent cause of cancer-related deaths in Hong Kong. According to the latest data from the Hong Kong Cancer Registry, there were 1,745 new liver cancer cases and 1,499 liver cancer reported deaths in 2008. Since little is known about the causes of liver cancer, effective treatment has yet to be developed.

 

There is a significant gender bias in liver cancer incidence. In Hong Kong, men are 3 times more likely to develop liver cancer than women. In certain areas of China and Japan, liver cancer is seen 7 times more frequently in men. Researchers have examined risk factor exposures such as occupation, alcohol drinking, cigarette smoking and family history, etc. to explain the gender disparities, but none of these could fully account for this difference. Although it has been postulated that male sex hormone or androgen may lead to a dominant sex disparity in liver cancer risk, this has never been conclusively shown.

 

From left: Prof. Alfred Sze Lok CHENG, Prof. Joseph J.Y. SUNG and Dr. Hai FENG discover the reason why liver cancer is more prevalent in men than in women.

From left: Prof. Alfred Sze Lok CHENG, Prof. Joseph J.Y. SUNG and Dr. Hai FENG discover the reason why liver cancer is more prevalent in men than in women.

Knowledge in the function of androgen receptor is crucial for studying the relationship between androgen and liver cancer. Androgen receptor is the protein that binds to, and is stimulated by androgen in cells. Once activated, androgen receptor controls gene expression resulting in a signaling cascade of biochemical reactions. However, the relationship between androgen receptor and liver cancer has not been fully explored.  

 

Since 2008, researchers of the Institute of Digestive Disease at The Chinese University of Hong Kong (CUHK) have conducted a genomic location analysis in liver cancer cells. Out of more than 17,000 human genes, they discovered that a gene called Cell Cycle-Related Kinase (CCRK) was directly controlled by androgen receptor. They further found that CCRK was critical for the induction of signaling pathway leading to abnormal liver cell growth and tumor formation.

 

Seventy percent (70%) of patients with liver cancer were found to produce high levels of CCRK. More importantly, these patients were more likely to have late-stage cancers and also lived shorter than those patients with low CCRK level. Using mouse models, the researchers then found that either lowering the level or blocking the signaling pathway of CCRK in liver cancer cells could significantly reduce the tumor growth rate.The results of this study were published online in July in an authoritative biomedical journal - Journal of Clinical Investigation.

 

From left: Prof. Alfred Sze Lok CHENG, Prof. Joseph J.Y. SUNG and Dr. Hai FENG discover the reason why liver cancer is more prevalent in men than in women.

 

'This study has a potential clinical impact as it depicts the correlation between androgen receptor and liver cancer development. It also provides an explanation on why men have a higher risk of liver cancer than women,' said Prof. Joseph J.Y. Sung, the Vice-Chancellor of CUHK and Mok Hing Yiu Professor of Medicine, and the research team leader of this project. 'If one can continue to work on possible ways of blocking the androgen receptor-CCRK pathway, there is a chance that a novel treatment of liver cancer can be developed.'

 

Currently, the traditional methods of treating liver cancer include surgical resection and chemotherapy. However, not all patients are suitable for surgery, while chemotherapy is associated with unwanted side effects and has low efficacy. The CUHK study has validated that CCRK is an important gene that has a potential to cause liver cancer.  CCRK can be tested as a new targeted therapy in future.

More Press Releases

CUHK Uncovers a New Strategy to Turn “Cold” Liver Tumour “Hot” Leading to an Effective and Durable Combined Immunotherapy

CUHK Uncovers a New Strategy to Turn “Cold” Liver Tumour “Hot” Leading to an Effective and Durable Combined Immunotherapy

Research
CUHK Discovers Up to 30% of Asymptomatic Subjects in Hong Kong Suffered from Pre-cancerous Bowel Tumors

CUHK Discovers Up to 30% of Asymptomatic Subjects in Hong Kong Suffered from Pre-cancerous Bowel Tumors

Research
CUHK Develops Biohybrid Soft Microrobots with a Rapid Endoluminal Delivery Strategy for Gastrointestinal Diseases

CUHK Develops Biohybrid Soft Microrobots with a Rapid Endoluminal Delivery Strategy for Gastrointestinal Diseases

Research
Results of the First 3,500 Participants of the CUHK Jockey Club Multi-Cancer Prevention Programme Demonstrate that “One-stop Multi-Cancer Screening” is Effective

Results of the First 3,500 Participants of the CUHK Jockey Club Multi-Cancer Prevention Programme Demonstrate that “One-stop Multi-Cancer Screening” is Effective

Health Campaign
CUHK Study Finds Earlier Endoscopy Did Not Reduce Mortality and Risk of Further Bleeding in Acute Upper Gastrointestinal Bleeding Patients

CUHK Study Finds Earlier Endoscopy Did Not Reduce Mortality and Risk of Further Bleeding in Acute Upper Gastrointestinal Bleeding Patients

Research
CUHK Launches Multi-Cancer Prevention Programme Providing Free Screening to 10,000 HK Residents to Study Links with Obesity

CUHK Launches Multi-Cancer Prevention Programme Providing Free Screening to 10,000 HK Residents to Study Links with Obesity

Health Campaign
CUHK Study Sees Increasing Global Incidence of Colorectal Cancer Among Younger People

CUHK Study Sees Increasing Global Incidence of Colorectal Cancer Among Younger People

Research
CUHK Discovers an Essential Oncogene in Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma

CUHK Discovers an Essential Oncogene in Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma

Research
CUHK Study Proves Ablative Chemoembolization Doubles the Progression-Free Survival for Liver Cancer Patients

CUHK Study Proves Ablative Chemoembolization Doubles the Progression-Free Survival for Liver Cancer Patients

Research
CUHK-DGIST-ETH Zurich Establish Joint Laboratory on Nano-technology for Gastrointestinal and Cardiovascular Diseases

CUHK-DGIST-ETH Zurich Establish Joint Laboratory on Nano-technology for Gastrointestinal and Cardiovascular Diseases

International collaboration
CUHK Study Reveals Patients with Recovery of Hepatitis B Still at Risk of Liver Cancer

CUHK Study Reveals Patients with Recovery of Hepatitis B Still at Risk of Liver Cancer

Research
CUHK Announces World’s First Systematic Review of the Global Incidence and Prevalence of Inflammatory Bowel Diseases in the 21st Century Reveals Surge in Hong Kong in past 30 years

CUHK Announces World’s First Systematic Review of the Global Incidence and Prevalence of Inflammatory Bowel Diseases in the 21st Century Reveals Surge in Hong Kong in past 30 years

Research
CUHK Collaborates with Australian Experts to Untangle Mystery of Eastern Inflammatory Bowel Disease Gut Microbiota

CUHK Collaborates with Australian Experts to Untangle Mystery of Eastern Inflammatory Bowel Disease Gut Microbiota

Research
CUHK and ETH Zurich Forge an Alliance on Innovative Technologies for Gastrointestinal Diseases

CUHK and ETH Zurich Forge an Alliance on Innovative Technologies for Gastrointestinal Diseases

International collaboration
CUHK Organizes First ‘Bowel Cancer Awareness Month’

CUHK Organizes First ‘Bowel Cancer Awareness Month’

Health Campaign
CUHK Discovers Fatty Liver Causing Severe Liver Fibrosis or Cirrhosis in 1 Out of 5 Diabetic Patients

CUHK Discovers Fatty Liver Causing Severe Liver Fibrosis or Cirrhosis in 1 Out of 5 Diabetic Patients

Research
CUHK World’s First Study Confirms A New Colorectal Cancer High Risk Group

CUHK World’s First Study Confirms A New Colorectal Cancer High Risk Group

Research
The Chinese University of Hong Kong and Imperial College Collaborate on Healthcare Innovation and Biomedical Robotics

The Chinese University of Hong Kong and Imperial College Collaborate on Healthcare Innovation and Biomedical Robotics

International collaboration
CUHK Reveals Effectiveness of TEA for Treating Liver Cancer with a 70% Chance of Completely Destroying Tumor

CUHK Reveals Effectiveness of TEA for Treating Liver Cancer with a 70% Chance of Completely Destroying Tumor

Research
CUHK Welcomes Government’s Proposal on Bowel Cancer Screening Territory-wide Bowel Cancer Screening Programme Shows 14% of Participants Diagnosed with Bowel Cancer or Pre-cancer

CUHK Welcomes Government’s Proposal on Bowel Cancer Screening Territory-wide Bowel Cancer Screening Programme Shows 14% of Participants Diagnosed with Bowel Cancer or Pre-cancer

Research
CUHK Establishes State Key Laboratory of Digestive Disease to Improve Diagnosis and Treatment of Digestive Diseases

CUHK Establishes State Key Laboratory of Digestive Disease to Improve Diagnosis and Treatment of Digestive Diseases

Research
CUHK-HCC Score Accurately Predicts Risk of Liver Cancer in Chronic Hepatitis B Patients Receiving Antiviral Therapy

CUHK-HCC Score Accurately Predicts Risk of Liver Cancer in Chronic Hepatitis B Patients Receiving Antiviral Therapy

Research
CUHK Received Four Ministry of Education Higher Education Outstanding Scientific Research Output Awards The Highest Share among Hong Kong Institutions

CUHK Received Four Ministry of Education Higher Education Outstanding Scientific Research Output Awards The Highest Share among Hong Kong Institutions

Awards and honors
CUHK discovers that 40% of Individuals at Risk of Coronary Heart Disease have Pre-cancerous Bowel Tumors

CUHK discovers that 40% of Individuals at Risk of Coronary Heart Disease have Pre-cancerous Bowel Tumors

Research
CUHK will hold 'SARS A Decade On: A Conference for the Health Professionals'

CUHK will hold 'SARS A Decade On: A Conference for the Health Professionals'

Symposium
Bowel Cancer Will Become Top Cancer in Hong Kong CUHK Introduces Colon Pill Camera to Prevent Bowel Cancer

Bowel Cancer Will Become Top Cancer in Hong Kong CUHK Introduces Colon Pill Camera to Prevent Bowel Cancer

Surgical advancement
Antiviral Therapy Can Prevent Liver Cancer Recurrence CUHK Represents HK to Draw Up Asian Pacific Treatment Guideline for Chronic Hepatitis B

Antiviral Therapy Can Prevent Liver Cancer Recurrence CUHK Represents HK to Draw Up Asian Pacific Treatment Guideline for Chronic Hepatitis B

Research
CUHK Introduces Double Balloon Enteroscopy Service to Manage Small Bowel Diseases

CUHK Introduces Double Balloon Enteroscopy Service to Manage Small Bowel Diseases

Clinical service

Our Expert List

Many experts under the Faculty of Medicine are available for media interview.
Please click here for the expert list or contact us.